Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2022 Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2022 Earnings Call Transcript February 28, 2023

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals’ Fourth Quarter and Full Year 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call up for your questions. Please be advised that today’s conference is being recorded. I’d now like to turn the call over...